Latest News:- Immunochemistry Market in Americas: Consumables is expected to lead the Product segment during 2024-2028

Immunochemistry Market in Americas to grow at a CAGR of 6.98% during 2024-2028

The Immunochemistry Market in Americas is expected to grow at a CAGR of 6.98% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 3621.75 million. The immunochemistry market in the Americas is propelled by the introduction of new products, which bring about innovative technologies, advanced assays, and superior instrumentation. These launches cater to the evolving requirements of healthcare professionals and researchers, providing enhanced sensitivity, specificity, and ease of use. New product introductions foster competition, promote the adoption of advanced immunochemistry solutions, and contribute to market expansion. Notable recent launches in the Americas include F. Hoffmann La Roche's introduction of vabysmo (faricimab) in March 2024, a treatment for diabetic macular edema (DME) and neovascular or wet age-related macular degeneration (nAMD) in India. 

Get more information on Immunochemistry Market in Americas by requesting a sample report

The Consumables subsegment is expected to dominate the Product segment during the forecast period 

Technavio analysts predict that the Consumables subsegment will lead the Product segment during 2024 and 2028 In the immunochemistry market within the Americas, the consumable product segment plays a pivotal role, catering to a diverse range of reagents and kits indispensable for conducting immunochemical assays, diagnostics, and research activities. Key consumable product categories include immunoassay kits, antibodies, and substrates/enzymes. Immunoassay kits, such as ELISA kits, offer ready-to-use solutions containing all essential components for executing specific immunoassays, enabling the detection and quantification of proteins, hormones, or antibodies in biological samples. Monoclonal and polyclonal antibodies, targeting distinct antigens or proteins of interest, serve as primary or secondary reagents in immunochemical assays for accurate detection and quantification. Substrates and enzymes, integral to ELISA and other immunochemical assays, facilitate signal amplification and detection via chromogenic, fluorogenic, or chemiluminescent substrates.

Here are the various ways based on which the market is segmented: 

• Product
  • Consumables
  • Equipment
• Application
  • Infectious disease
  • Cardiology
  • Oncology
  • Autoimmune disease
  • Nephrology and others
• Geography
  • Americas

Reasons to Purchase the Global Immunochemistry Market in Americas Market Research Report by Technavio. What is in it for you?

• Wealth of Experience: Technavio is an established name in the world of market research. It holds an expertise of more than 20 years in the field, has published 21,000+ reports thereby extensively covering the area in various industries and range of regions
• Insight into Current Market Trends: Our research reports provide our readers insights into the latest market intelligence, competitor strategies, market trends, changes taking place in the industry and customer preferences, forecasted market opportunities that influence them to make better business decisions
• High ROI with Extensive Hands-on Research: Technavio is renowned for offering personalized market research reports as per unique business needs, delving deep into specific markets, product segments and demographics. Additionally, it is also well-known for providing high return on investments through its wide collection of data at pocket-friendly rates

There are several factors that are causing the market to flourish growing geriatric population

Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report

Research Analysis Overview

The Immunochemistry market in the Americas is witnessing significant growth due to the increasing demand for advanced diagnostic tools for cancer and chronic illnesses. Immunochemistry, also known as Immunohistochemistry (IHC), is a vital technique used for disease diagnosis, particularly in cancer research. IHC utilizes antibodies to identify specific proteins in cells and tissues, with mass spectrometric detection providing enhanced sensitivity and specificity. Multiplexed IHC and anti-PD-1 immunotherapy are emerging trends in the field, enabling the detection of multiple biomarkers in a single test and improving the efficacy of cancer treatments. Machine learning algorithms are being integrated into IHC protocols to enhance diagnostic accuracy, especially in complex cases such as non-small-cell lung cancer. Immunochemistry products are essential diagnostic tools for healthcare professionals, with applications in cardiovascular disorders and other chronic illnesses. The market is expected to grow further with the advent of mutation-specific immunochemistry tests and personalized medicine approaches. The global immunohistochemistry market is also witnessing the adoption of automation, digital imaging, and transcriptome/RNA sequencing technologies, such as the VENTANA DP 600 system, to streamline workflows and improve diagnostic efficiency. Pathologists play a crucial role in interpreting IHC results, and the geriatric population represents a significant market opportunity due to the increased prevalence of chronic diseases in this demographic.

Market Research Overview

According to Technavio, the Immunochemistry Market in the Americas is a significant segment of the global Pharmaceuticals Market, which encompasses entities involved in the research and development (R&D) or manufacturing of various pharmaceutical offerings, including generic and non-generic drugs, veterinary drugs, and life sciences tools and services. The size of the global healthcare industry, of which the pharmaceuticals market is a part, is determined by Technavio based on the consolidated revenue generated by providers of healthcare equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global pharmaceuticals market will be fueled by several key factors, among which is the increasing aging population. The global population aged 60 years and above is projected to experience substantial growth, leading to a heightened demand for healthcare solutions, including pharmaceuticals, to address the unique health needs of this demographic.

The Immunochemistry Market in Americas is experiencing significant growth, fueled by the growing geriatric population. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/